Clinical Trial Update: Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer

View source ↗

Summary

Clinical trial update comparing steroidal aromatase inhibitors with progestogens for advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Carcinoma Breast Stage IV | Status: UNKNOWN